Results 91 to 100 of about 224,404 (241)

Canadian evidence‐based guidelines on spinal procedures for chronic pain

open access: yesAnaesthesia, EarlyView.
Summary Introduction Interventional procedures are commonly used to diagnose and treat chronic pain of spinal origin but guidance on: their indications; frequency; technical conduct; requirements for image guidance; outcome measurement; and management of complications is lacking.
Anuj Bhatia   +26 more
wiley   +1 more source

Evaluation of Serum Osteocalcin and Osteopontin Levels as Bone Biochemical Markers in Postmenopausal Women.

open access: yesمجله كليه طب الكندي, 2013
Background: Studies discussing the correlation between biochemical markers of bone turnover and the diagnosis of osteoporosis in postmenopausal Iraqi women are rare.
Kisma M Turki   +2 more
doaj  

Weight-adjusted waist index as a new predictor of osteoporosis in postmenopausal patients with T2DM

open access: yesScientific Reports
This study aimed to investigate the predictive value of the weight-adjusted waist index (WWI) for osteoporosis in postmenopausal patients with type 2 diabetes mellitus (T2DM).
Guohui Du   +10 more
doaj   +1 more source

Parathyroid carcinoma as an overlooked etiology of osteoporosis in postmenopausal women: a case report

open access: yesFrontiers in Endocrinology
Parathyroid carcinoma (PC), an extremely rare endocrine malignancy, disrupts calciumphosphorus homeostasis and lead to musculoskeletal system disorders including osteoporosis, bone pain and pathological fractures.
Jing Su   +4 more
doaj   +1 more source

Serum IL-17 and postmenopausal osteoporosis

open access: yesمجلة كلية الطب, 2016
Background: Osteoporosis is a bone condition that makes bones thininer and more fragile because of reduced bone density and it puts people at risk of fractures, especially of the hip, spinal vertebrae and wrist. Objective: This study will highlighted the
Tharwa H. AL-Tai
doaj   +1 more source

Importance of Biochemical Markers in Postmenopausal and Senile Osteoporosis

open access: yes, 2002
Recently, the biochemical markers are widely used in order to evaluate the bone turnover. This study was planned to investigate the role of biochemical markers and Bone Mineral Density(BMD) in postmenopausal (PMO) and senile osteoporosis (SO) patients ...
Deniz Evcik, Mustafa Serteser
core  

Bone Health and Aging in Klinefelter Syndrome

open access: yesAndrology, EarlyView.
ABSTRACT Klinefelter syndrome (KS) is typically diagnosed in young adults, but advances in prenatal testing have led to its recognition at a much earlier age. Conversely, diagnosis in late adulthood remains uncommon, but still occurs. Independently from the age at diagnosis, KS individuals now receive more accurate and tailored care management than in ...
Filippo Vignali   +4 more
wiley   +1 more source

Daily supplement of sesame oil prevents postmenopausal osteoporosis via maintaining serum estrogen and aromatase levels in rats

open access: yesScientific Reports
Estrogen deficiency is one of the main causes of postmenopausal osteoporosis in elderly women. Hormone replacement therapy has been employed to manage postmenopausal osteoporosis; however, it has raised concerns related to heart attacks and breast cancer.
Che-Chia Hsu   +6 more
doaj   +1 more source

Association between risk factors and bone mineral density and the development of a self-assessment tool for early osteoporosis screening in postmenopausal women with type 2 diabetes [PDF]

open access: yesPeerJ
Background Both diabetes and osteoporosis have developed into major global public health problems due to the increasing aging population. It is crucial to screen populations at higher risk of developing osteoporosis for disease prevention and management ...
Xiaoyu Chen   +7 more
doaj   +2 more sources

Efficacy and safety of bazedoxifene for postmenopausal osteoporosis [PDF]

open access: yes, 2011
Hisaya Kawate, Ryoichi TakayanagiDepartment of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JapanAbstract: Bazedoxifene, a novel selective estrogen receptor modulator, has been developed to have ...
Ryoichi Takayanagi   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy